Applied Biosciences Corp.
APPB · OTC
3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | |
|---|---|---|---|---|
| Revenue | $0 | $1 | $1 | $0 |
| % Growth | -87.7% | 2.3% | 257.9% | – |
| Cost of Goods Sold | $0 | $0 | $1 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -358.5% | 39.6% | 26.2% | 21.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $2 | $1 |
| SG&A Expenses | $0 | $3 | $3 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $1 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $3 | $3 | $2 |
| Operating Income | -$1 | -$3 | -$3 | -$1 |
| % Margin | -781.3% | -427.1% | -374.3% | -303.5% |
| Other Income/Exp. Net | -$0 | -$2 | -$0 | -$0 |
| Pre-Tax Income | -$1 | -$5 | -$3 | -$2 |
| Tax Expense | $0 | $0 | $0 | $1 |
| Net Income | -$1 | -$5 | -$3 | -$2 |
| % Margin | -865.3% | -646.1% | -371.9% | -1,202.8% |
| EPS | -0.04 | -0.34 | -0.22 | -0.16 |
| % Growth | 88.4% | -54.5% | -37.5% | – |
| EPS Diluted | -0.056 | -0.34 | -0.22 | -0.16 |
| Weighted Avg Shares Out | 14 | 14 | 12 | 15 |
| Weighted Avg Shares Out Dil | 14 | 14 | 12 | 15 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $1 | $1 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$4 | -$2 | -$2 |
| % Margin | -817.9% | -518.8% | -281.4% | -1,094.4% |